TrialWire™ Platform was engaged by the sponsor when the study was failing to recruit. The study needed 12 more patients – only 1 had been recruited.

The main challenge was a multi-day confinement which required the Platform to target specific people who could accommodate this protocol.

All patent engagement activity was funneled through the Platform so patients could be quickly online screened and connected to their nearest site for follow-up.

The study was fully recruited.